Greenwich LifeSciences, Inc. (GLSI) Financials
GLSI Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 9.1 million | 297287 |
| 2023-06-30 | 11.0 million | 301546 |
| 2023-03-31 | 11.9 million | 235575 |
| 2022-12-31 | 13.5 million | 262905 |
GLSI Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -1.8 million | 594522 |
| 2023-06-30 | -966977 | 594522 |
| 2023-03-31 | -1.6 million | 594522 |
| 2022-12-31 | -2.2 million | 594522 |
GLSI Net Income
No data available :(
GLSI Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 9.1 million | - | - |
| 2023-06-30 | 10.9 million | - | - |
| 2023-03-31 | 11.9 million | - | - |
| 2022-12-31 | 13.5 million | - | - |
GLSI Shares Outstanding
GLSI Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | - | 2.2 million | 344758 | - |
| 2023-06-30 | - | 1.4 million | 368259 | - |
| 2023-03-31 | - | 1.8 million | 413175 | - |
| 2022-12-31 | - | 2.5 million | 436579 | - |
GLSI Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | - | 903 |
| 2023-06-30 | - | 903 |
| 2023-03-31 | - | 903 |
| 2022-12-31 | - | 903 |
GLSI
Price: $13.12
52 week price:
Earnings Per Share: -0.70 USD
P/E Ratio: -12.07
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 30476
Market Capitalization: 227.7 million